ACAD
17.89
-1.47
-7.59%
AEMD
4.57
-0.33
-6.73%
APRI
1.144
-0.026
-2.1880%
ARNA
1.51
-0.06
-3.82%
ATEC
0.395
-0.005
-1.250%
CNAT
1.69
-0.15
-8.15%
CRXM
0.25
0.00
0.00%
CYTX
0.14
-0.039
-21.8192%
DXCM
52.05
-9.93
-16.02%
GNMK
5.1
+0.02
+0.39%
HALO
7.35
-0.55
-6.9608%
ILMN
136.69
+0.64
+0.47%
INNV
0.035
-0.003
-7.652%
INO
5.885
-0.125
-2.080%
ISCO
2.75
+0.35
+14.58%
ISIS
57.56
0.00
0.00%
LGND
89.17
-3.33
-3.60%
LPTN
0.159
-0.001
-0.8744%
MBVX
0.55
+0.01
+1.8333%
MEIP
1.19
-0.05
-4.0403%
MNOV
4.09
-0.06
-1.45%
MRTX
18.915
-1.345
-6.639%
MSTX
0.415
+0.005
+1.2204%
NBIX
32.75
-3.24
-9.00%
NUVA
40.995
-0.455
-1.098%
ONCS
1.53
-0.16
-9.47%
ONVO
1.99
-0.1
-4.78%
OREX
1.745
-0.095
-5.163%
OTIC
12.82
-0.98
-7.10%
QDEL
16.11
-0.29
-1.77%
RCPT
231.96
0.00
0.00%
RGLS
5.49
-0.45
-7.58%
RMD
56.99
-0.43
-0.75%
SCIE
0.001
0.00
-20.0000%
SPHS
1.654
-0.026
-1.5357%
SRNE
4.91
-0.14
-2.77%
TROV
3.541
-0.309
-8.026%
VICL
0.339
+0.007
+1.9537%
VOLC
18
0.00
0.00%
ZGNX
8.36
-0.13
-1.53%
ACAD
17.89
-1.47
-7.59%
AEMD
4.57
-0.33
-6.73%
APRI
1.144
-0.026
-2.1880%
ARNA
1.51
-0.06
-3.82%
ATEC
0.395
-0.005
-1.250%
CNAT
1.69
-0.15
-8.15%
CRXM
0.25
0.00
0.00%
CYTX
0.14
-0.039
-21.8192%
DXCM
52.05
-9.93
-16.02%
GNMK
5.1
+0.02
+0.39%
HALO
7.35
-0.55
-6.9608%
ILMN
136.69
+0.64
+0.47%
INNV
0.035
-0.003
-7.652%
INO
5.885
-0.125
-2.080%
ISCO
2.75
+0.35
+14.58%
ISIS
57.56
0.00
0.00%
LGND
89.17
-3.33
-3.60%
LPTN
0.159
-0.001
-0.8744%
MBVX
0.55
+0.01
+1.8333%
MEIP
1.19
-0.05
-4.0403%
MNOV
4.09
-0.06
-1.45%
MRTX
18.915
-1.345
-6.639%
MSTX
0.415
+0.005
+1.2204%
NBIX
32.75
-3.24
-9.00%
NUVA
40.995
-0.455
-1.098%
ONCS
1.53
-0.16
-9.47%
ONVO
1.99
-0.1
-4.78%
OREX
1.745
-0.095
-5.163%
OTIC
12.82
-0.98
-7.10%
QDEL
16.11
-0.29
-1.77%
RCPT
231.96
0.00
0.00%
RGLS
5.49
-0.45
-7.58%
RMD
56.99
-0.43
-0.75%
SCIE
0.001
0.00
-20.0000%
SPHS
1.654
-0.026
-1.5357%
SRNE
4.91
-0.14
-2.77%
TROV
3.541
-0.309
-8.026%
VICL
0.339
+0.007
+1.9537%
VOLC
18
0.00
0.00%
ZGNX
8.36
-0.13
-1.53%
Home » Archive by Category

Xconomy

In Significant Reversal, Prostate Drug Met Primary Goal After All

November 10, 2015 – 1:03 pm

After getting something worse than a lump of coal for Christmas last year, Sophiris Bio got an early present for the 2015 holidays— its experimental prostrate drug met the primary goal of a…

[[Click headline to continue reading.]]

In Significant Reversal, Prostate Drug Met Primary Goal After All

November 10, 2015 – 1:03 pm

After getting something worse than a lump of coal for Christmas last year, Sophiris Bio got an early present for the 2015 holidays— its experimental prostrate drug met the primary goal of a…

[[Click headline to continue reading.]]

Avalon, GSK Extend Collaboration with Startup Focused on ALS

November 9, 2015 – 1:00 am

San Diego’s Avalon Ventures has started a new biotech focused on Lou Gehrig’s disease, the neuro-degenerative disease that claimed the life of the Hall of Fame New York Yankees first baseman, whose…

[[Click headline to continue reading.]]

Avalon, GSK Extend Collaboration with Startup Focused on ALS

November 9, 2015 – 1:00 am

[Corrected 11/12/15, 9:30 am. See below.] San Diego’s Avalon Ventures has started a new biotech focused on Lou Gehrig’s disease, the neuro-degenerative disease that claimed the life of the Hall of…

[[Click headline to continue reading.]]

Avalon, GSK Extend Collaboration with Startup Focused on ALS

November 9, 2015 – 1:00 am

[Corrected 11/12/15, 9:30 am. See below.] San Diego’s Avalon Ventures has started a new biotech focused on Lou Gehrig’s disease, the neuro-degenerative disease that claimed the life of the Hall of…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: KaloBios, Atreca, Acadia, Twist & More

November 6, 2015 – 1:02 pm

There were drips and drabs of news out west this week, but compared to recent weeks with former Silicon Valley darling Theranos taking a beating, or 23andMe revving its engines, it’s been…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: KaloBios, Atreca, Acadia, Twist & More

November 6, 2015 – 1:02 pm

There were drips and drabs of news out west this week, but compared to recent weeks with former Silicon Valley darling Theranos taking a beating, or 23andMe revving its engines, it’s been…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: KaloBios, Atreca, Acadia, Twist & More

November 6, 2015 – 1:02 pm

There were drips and drabs of news out west this week, but compared to recent weeks with former Silicon Valley darling Theranos taking a beating, or 23andMe revving its engines, it’s been…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: KaloBios, Atreca, Acadia, Twist & More

November 6, 2015 – 1:02 pm

There were drips and drabs of news out west this week, but compared to recent weeks with former Silicon Valley darling Theranos taking a beating, or 23andMe revving its engines, it’s been…

[[Click headline to continue reading.]]

Seven Major Cancer Centers To Pool Patients’ Gene, Health Data

November 6, 2015 – 10:30 am

Here and there, the genetic information of a cancer patient has helped a doctor find that person the right drug or steer her away from the wrong one. But the use of genetic knowledge to improve…

[[Click headline to continue reading.]]